| Literature DB >> 30392727 |
Leli Wang1, Vinothkannan Ravichandran2, Yulong Yin3, Jia Yin4, Youming Zhang5.
Abstract
The mammalian gut has a remarkable abundance of microbes. These microbes have strong potential to biosynthesize distinct metabolites that are promising drugs, and many more bioactive compounds have yet to be explored as potential drug candidates. These small bioactive molecules often mediate important host-microbe and microbe-microbe interactions. In this review, we provide perspectives on and challenges associated with three mining strategies - culture-based, (meta)genomics-based, and metabolomics-based mining approaches - for discovering natural products derived from biosynthetic gene clusters (BGCs) in mammalian gut microbiota. In addition, we comprehensively summarize the structures, biological functions, and BGCs of these compounds. Improving these techniques, including by using combinatorial approaches, may accelerate drug discovery from gut microbes.Entities:
Keywords: biosynthetic gene clusters; culture-based mining approaches; genome metagenomics; gut microbiota; metabolomics; natural products
Mesh:
Substances:
Year: 2018 PMID: 30392727 DOI: 10.1016/j.tibtech.2018.10.003
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536